Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | Cannabinoids
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Cannabinoids
Bhaskaran D, Savage J, Patel A,
Collinson F, Mant R, Boele F, Brazil L, Meade S, Buckle P, Lax S,
Billingham L, Short SC.
A
randomised phase II trial of temozolomide with or without
cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT):
protocol for a multi-centre, double-blind, placebo-controlled
trial.
BMC
Cancer. 2024 Jan
15;24(1):83. doi:
10.1186/s12885-023-11792-4. PMID:
38225549. Interventional
study protocol. ˍ